India Molecular Diagnostic Controls Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Healthcare India Molecular Diagnostic Controls Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

India Molecular Diagnostic Controls Market Analysis

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
Buy Now Buy Now

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of India molecular diagnostic controls market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET application COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. REGULATIONS OF EUROPE, AFRICA, AND INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET
  6. market overview
    1. DRIVERS
      1. INCREASE IN PREVALENCE OF INFECTIOUS DISEASES AND CANCER
      2. GROWING ADOPTION OF THIRD-PARTY QUALITY CONTROLS
      3. RISE IN CLEARANCE FROM REGULATORY AGENCIES
      4. INCREASE IN NUMBER OF ACCREDITED CLINICAL LABORATORIES
    2. RESTRAINT
      1. HIGH COSTS ASSOCIATED WITH QUALITY CONTROL PROCESS
    3. OPPORTUNITIES
      1. COLLABORATIONS BETWEEN ACADEMIC INSTITUTIONS, HOSPITALS, AND COMPANIES
      2. INCREASE IN RESEARCH ON CANCER BIOMARKERS
      3. ADVANCED DIAGNOSIS INFRASTRUCTURE
    4. CHALLENGE
      1. UNFAVORABLE REIMBURSEMENT POLICIES FOR MOLECULAR TESTS
  7. IMPACT OF COVID-19 ON INDIA MOLECULAR DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC INITIATIVES BY MARKET PLAYERS DURING COVID-19
    5. CONCLUSION
  8. India molecular diagnostic controls MARKET, BY PRODUCT
    1. overview
    2. Independent Controls
    3. Instrument Specific Controls
      1. Polymerase Chain Reaction (PCR)
      2. Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. DNA Sequencing & Next Generation Sequencing
      4. In Situ Hybridization (ISH)
      5. DNA Microarray
  9. India molecular diagnostic controls MARKET, BY analyte TYPE
    1. overview
    2. Single Analyte Controls
    3. Multi Analyte Controls
  10. India molecular diagnostic controls MARKET, BY application
    1. overview
    2. Infectious Disease
      1. Hepatitis
      2. Human papillomavirus (HPV)
      3. HIV
      4. Health care-associated infections (HAIs)
      5. Influenza
      6. Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG)
      7. TB
      8. Others
    3. Oncology
    4. Genetic Testing
    5. Others
  11. India molecular diagnostic controls MARKET, BY end user
    1. overview
    2. Clinical Laboratories
    3. Hospitals
    4. IVD Manufacturers & Contract Research Organisations
    5. Academic & Research Institutes
    6. Others
  12. India molecular diagnostic controls MARKET, BY distribution channel
    1. overview
    2. Retail Sales
    3. Direct Tenders
  13. India Molecular Diagnostic Controls Market, By Region
    1. INDIA
  14. EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET, COMPANY landscape
    1. company share analysis: India
  15. swot analysis
  16. Company profile
    1. Bio-Rad Laboratories, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    2. Randox Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    3. Technopath Clinical Diagnostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    4. Thermo fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. ASURAGEN, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. BIOMÉRIEUX SA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. EKF Diagnostics Holdings plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. ELITechGroup
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Helena Laboratories (UK) Limited trading
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. Merck KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. microbiologics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Molbio Diagnostics Pvt. Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. SERACARE LIFE SCIENCES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. QNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. QUIDEL CORPORATION
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

List of Table

TABLE 1 India molecular diagnostic controls Market, By product, 2019-2028 (USD MILLION)

TABLE 2 India Independent Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 3 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 4 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 5 India molecular diagnostic controls Market, By Analyte type, 2019-2028 (USD MILLION)

TABLE 6 India Single Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 7 India Multi Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 8 India molecular diagnostic controls Market, By application, 2019-2028 (USD MILLION)

TABLE 9 India Infectious Disease in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 10 India Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 11 India Oncology in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 12 India Genetic Testing in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 13 India Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 14 India molecular diagnostic controls Market, By end user, 2019-2028 (USD MILLION)

TABLE 15 India Clinical Laboratories in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 16 India Hospitals in Molecular Diagnostic Controls Market, By Region r, 2019-2028 (USD Million)

TABLE 17 India IVD Manufacturers & Contract Research Organisations in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 18 India Academic & Research Institutes in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 19 India Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 20 India molecular diagnostic controls Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 21 India Retail Sales in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 22 India Direct Tenders in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)

TABLE 23 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)

TABLE 24 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)

TABLE 25 India Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)

TABLE 26 India Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 27 India Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)

TABLE 28 India Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)

TABLE 29 India Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)

List of Figure

FIGURE 1 India molecular diagnostic controls MARKET: SEGMENTATION

FIGURE 2 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: DATA TRIANGULATION

FIGURE 3 India molecular diagnostic controls market: DROC ANALYSIS

FIGURE 4 India molecular diagnostic controls market: Global VS. REGIONAL MARKET ANALYSIS

FIGURE 5 India molecular diagnostic controls market: COMPANY RESEARCH ANALYSIS

FIGURE 6 India molecular diagnostic controls market: MULTIVARIATE MODELLING

FIGURE 7 India molecular diagnostic controls market: INTERVIEW DEMOGRAPHICS

FIGURE 8 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 India molecular diagnostic controls market: MARKET application COVERAGE GRID

FIGURE 11 India molecular diagnostic controls market: SEGMENTATION

FIGURE 12 Europe is expected to DOMINATE THE India molecular diagnostic controls market AND india IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 increasing prevalence of infectious diseases and cancer is expected to DRIVe THE India molecular diagnostic controls market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 product SEGMENT is expected to account for the largest share of the India molecular diagnostic controls MARKET in 2021 & 2028

FIGURE 15 InDIA is the fastest growing market FOR the India Molecular diagnostic controls MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGE OF India molecular diagnostics controls Market

FIGURE 17 India molecular diagnostic controls MARKET: BY product, 2020

FIGURE 18 India molecular diagnostic controls MARKET: BY product, 2021-2028 (USD MILLION)

FIGURE 19 India molecular diagnostic controls MARKET: BY product, CAGR (2021-2028)

FIGURE 20 India molecular diagnostic controls MARKET: BY product, LIFELINE CURVE

FIGURE 21 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2020

FIGURE 22 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2021-2028 (USD MILLION)

FIGURE 23 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, CAGR (2021-2028)

FIGURE 24 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, LIFELINE CURVE

FIGURE 25 India molecular diagnostic controls MARKET: BY application, 2020

FIGURE 26 India molecular diagnostic controls MARKET: BY application, 2021-2028 (USD MILLION)

FIGURE 27 India molecular diagnostic controls MARKET: BY application, CAGR (2021-2028)

FIGURE 28 India molecular diagnostic controls MARKET: BY application, LIFELINE CURVE

FIGURE 29 India molecular diagnostic controls MARKET: BY end user, 2020

FIGURE 30 India molecular diagnostic controls MARKET: BY end user, 2021-2028 (USD MILLION)

FIGURE 31 India molecular diagnostic controls MARKET: BY end user, CAGR (2021-2028)

FIGURE 32 India molecular diagnostic controls MARKET: BY end user, LIFELINE CURVE

FIGURE 33 India molecular diagnostic controls MARKET: BY distribution channel, 2020

FIGURE 34 India molecular diagnostic controls MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 35 India molecular diagnostic controls MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 36 India molecular diagnostic controls MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 37 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: company share 2020 (%)

Frequently Asked Questions

The India Molecular Diagnostic Controls Market size will be worth USD 128.87 million by 2031 during the forecast period.
The India Molecular Diagnostic Controls Market growth rate is 13.7% during the forecast period.
The Rising Incidence of Diseases & Advances in Molecular Diagnostics are the growth drivers of the Molecular Diagnostic Controls Market.
The product, analyte type, application, end-user, and distribution channel are the factors on which the Molecular Diagnostic Controls Market research is based.
The major companies in the Molecular Diagnostic Controls Market are Thermo Fisher Scientific Inc. (U.S.), ASURAGEN, INC.(U.S.), Merck KGaA (Germany), SERACARE LIFE SCIENCES (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Abbott (U.S.), Microbiologics (U.S.).

Browse Related Pages

Banner